LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Buparlisib | 0.12 | uM | LJP5 | 1 | H05 | 72 | hr | 1235 | 4233 | 4474 | 0.9460 | 0.9411 |
MDA-MB-231 | Buparlisib | 0.12 | uM | LJP5 | 2 | H05 | 72 | hr | 1235 | 4256 | 4578 | 0.9296 | 0.9241 |
MDA-MB-231 | Buparlisib | 0.12 | uM | LJP5 | 3 | H05 | 72 | hr | 1235 | 4883 | 4929 | 0.9906 | 0.9906 |
MDA-MB-231 | Buparlisib | 0.37 | uM | LJP5 | 1 | H04 | 72 | hr | 1235 | 3610 | 4474 | 0.8068 | 0.7815 |
MDA-MB-231 | Buparlisib | 0.37 | uM | LJP5 | 2 | H04 | 72 | hr | 1235 | 3889 | 4578 | 0.8494 | 0.8345 |
MDA-MB-231 | Buparlisib | 0.37 | uM | LJP5 | 3 | H04 | 72 | hr | 1235 | 4464 | 4929 | 0.9056 | 0.9031 |
MDA-MB-231 | Buparlisib | 1.11 | uM | LJP5 | 1 | H03 | 72 | hr | 1235 | 2542 | 4474 | 0.5681 | 0.4748 |
MDA-MB-231 | Buparlisib | 1.11 | uM | LJP5 | 2 | H03 | 72 | hr | 1235 | 2780 | 4578 | 0.6072 | 0.5358 |
MDA-MB-231 | Buparlisib | 1.11 | uM | LJP5 | 3 | H03 | 72 | hr | 1235 | 3407 | 4929 | 0.6912 | 0.6621 |
MDA-MB-231 | Buparlisib | 3.33 | uM | LJP5 | 1 | H02 | 72 | hr | 1235 | 1262 | 4474 | 0.2820 | 0.0113 |
MDA-MB-231 | Buparlisib | 3.33 | uM | LJP5 | 2 | H02 | 72 | hr | 1235 | 1207 | 4578 | 0.2636 | -0.0125 |
MDA-MB-231 | Buparlisib | 3.33 | uM | LJP5 | 3 | H02 | 72 | hr | 1235 | 1582 | 4929 | 0.3209 | 0.1317 |
MDA-MB-231 | Buparlisib | 10 | uM | LJP5 | 1 | H01 | 72 | hr | 1235 | 506 | 4474 | 0.1131 | -0.3819 |
MDA-MB-231 | Buparlisib | 10 | uM | LJP5 | 2 | H01 | 72 | hr | 1235 | 390 | 4578 | 0.0852 | -0.4569 |
MDA-MB-231 | Buparlisib | 10 | uM | LJP5 | 3 | H01 | 72 | hr | 1235 | 624 | 4929 | 0.1266 | -0.2900 |
MDA-MB-231 | XL147 | 0.04 | uM | LJP5 | 1 | G12 | 72 | hr | 1235 | 4858 | 4474 | 1.0857 | 1.0905 |
MDA-MB-231 | XL147 | 0.04 | uM | LJP5 | 2 | G12 | 72 | hr | 1235 | 4938 | 4578 | 1.0785 | 1.0816 |
MDA-MB-231 | XL147 | 0.04 | uM | LJP5 | 3 | G12 | 72 | hr | 1235 | 5260 | 4929 | 1.0671 | 1.0661 |
MDA-MB-231 | XL147 | 0.12 | uM | LJP5 | 1 | G11 | 72 | hr | 1235 | 4743 | 4474 | 1.0600 | 1.0637 |
MDA-MB-231 | XL147 | 0.12 | uM | LJP5 | 2 | G11 | 72 | hr | 1235 | 5217 | 4578 | 1.1394 | 1.1431 |
MDA-MB-231 | XL147 | 0.12 | uM | LJP5 | 3 | G11 | 72 | hr | 1235 | 4926 | 4929 | 0.9993 | 0.9993 |
MDA-MB-231 | XL147 | 0.37 | uM | LJP5 | 1 | G10 | 72 | hr | 1235 | 4748 | 4474 | 1.0611 | 1.0649 |
MDA-MB-231 | XL147 | 0.37 | uM | LJP5 | 2 | G10 | 72 | hr | 1235 | 5019 | 4578 | 1.0962 | 1.0996 |
MDA-MB-231 | XL147 | 0.37 | uM | LJP5 | 3 | G10 | 72 | hr | 1235 | 4699 | 4929 | 0.9533 | 0.9526 |
MDA-MB-231 | XL147 | 1.11 | uM | LJP5 | 1 | G09 | 72 | hr | 1235 | 4927 | 4474 | 1.1011 | 1.1065 |